309 related articles for article (PubMed ID: 11160023)
1. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
3. Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.
Brahimi K; Badell E; Sauzet JP; BenMohamed L; Daubersies P; Guérin-Marchand C; Snounou G; Druilhe P
Infect Immun; 2001 Jun; 69(6):3845-52. PubMed ID: 11349050
[TBL] [Abstract][Full Text] [Related]
4. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
[TBL] [Abstract][Full Text] [Related]
5. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
Doolan DL; Hoffman SL
J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
[TBL] [Abstract][Full Text] [Related]
6. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
7. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
Dobaño C; Doolan DL
Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
Xu L; Pei X; Berzins K; Chaudhuri A
Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
[TBL] [Abstract][Full Text] [Related]
10. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
[TBL] [Abstract][Full Text] [Related]
11. Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome.
Dwivedi V; Vasco A; Vedi S; Dangi A; Arif K; Bhattacharya SM; Owais M
Vaccine; 2009 Jan; 27(3):473-82. PubMed ID: 18996429
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation.
Dobaño C; Widera G; Rabussay D; Doolan DL
Vaccine; 2007 Sep; 25(36):6635-45. PubMed ID: 17669562
[TBL] [Abstract][Full Text] [Related]
13. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
[TBL] [Abstract][Full Text] [Related]
14. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
[TBL] [Abstract][Full Text] [Related]
15. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
16. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
[TBL] [Abstract][Full Text] [Related]
17. Identification of karyopherin beta as an immunogenic antigen of the malaria parasite using immune mice and human sera.
Mohmmed A; Kishore S; Patra KP; Dasaradhi PV; Malhotra P; Chauhan VS
Parasite Immunol; 2005 May; 27(5):197-203. PubMed ID: 15987343
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
[TBL] [Abstract][Full Text] [Related]
19. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
20. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.
Wang R; Richie TL; Baraceros MF; Rahardjo N; Gay T; Banania JG; Charoenvit Y; Epstein JE; Luke T; Freilich DA; Norman J; Hoffman SL
Infect Immun; 2005 May; 73(5):2863-72. PubMed ID: 15845492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]